Clinical Trial Update: Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the immediate response to adalimumab and its impact on quality of life and comorbidity factors in adults with moderate to severe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2013-03-11